Are you under 70 years old?
Did you take Valsartan for at least 12 Months between 2014 and 2018?
Were you diagnosed with one of the following cancers after January 1, 2017?
Do You Qualify For A Valsartan Lawsuit?
Are you 70 years old or younger and have you recieved a cancer diagnosis after taking the prescription drug Valsartan? If so, you need to speak with an experienced Valsartan lawsuit attorney. TheLawfirm.com drug recall lawyers are focused on one thing: providing compassionate and experienced legal representation to the victims of recalled drugs.
You may be entitled to substantial financial compensation and we've won millions in settlements and payouts for our clients, including record settlements in wrongful death cases.
Valsartan Lawsuit - Cancers That Qualify:
Valsartan Lawsuit - Cancers That Don't Qualify:
How Can a Valsartan Recall Lawsuit Attorney Help Me?
In the first lawsuit filed against the makers of Valsartan, plaintiffs Elizabeth Duffy and John Duffy filed a federal complaint in the Southern District of New York against two drug makers and two drugstore chains for their role in manufacturing, distributing, and selling generic valsartan-containing drugs that were contaminated with NDMA, a substance the US Environmental Protection Agency (EPA) has categorized as a “probable human carcinogen”.
The legal action, which was filed on behalf of the plaintiffs and all similarly situated consumers, accuses Solco Healthcare and Prinston Pharmaceutical of manufacturing and distributing the potentially harmful drugs and blames drugstores Walgreen Co. and Throggs Neck Pharmacy of selling the drugs to consumers.
These drug makers and drugstores will not be on the only ones sued over their role in allowing this medicine to end up in the medicine cabinets of so many consumers.
Valsartan Recall: What you should know
In a matter of mere months, the previously little-known pharmaceutical ingredient valsartan has gone from relative obscurity to being at the center of multiple drug recalls and at least one potential class-action lawsuit.
Since 1996, valsartan, marketed by Novartis under the brand name Dioval, has been approved in the United States for the treatment of high blood pressure and, later, heart failure. However, beginning in July 2018, products containing valsartan were subject to a series of drug recalls over contamination concerns, developments that already have yielded at least one federal lawsuit seeking class-action status.
Valsartan Lawsuit Attorneys
The Valsartan Recall Attorneys at TheLawFirm.com are evaluating the potential for individual Valsartan Cancer Lawsuits for people who have taken various versions of Valsartan and have been diagnosed with various cancers. If you'd like more detail on the Valsartan recall, see our Valsartan recall side effects page or our Valsartan NDMA videos page.